دورية أكاديمية

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.

التفاصيل البيبلوغرافية
العنوان: Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
المؤلفون: Tao Ren, Jinlu Shan, Mengxia Li, Yi Qing, Chengyuan Qian, Guangjie Wang, Qing Li, Guoshou Lu, Chongyi Li, Yu Peng, Hao Luo, Shiheng Zhang, Yuxing Yang, Yi Cheng, Dong Wang, Shu-Feng Zhou
المصدر: Drug Design, Development & Therapy; 2015, Vol. 9, p2887-2910, 24p
قاعدة البيانات: Complementary Index
الوصف
تدمد:11778881
DOI:10.2147/DDDT.S82724